Article Details

TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024

Retrieved on: 2024-08-06 01:35:09

Tags for this article:

Click the tags to see associated articles and topics

TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024. View article details on hiswai:

Excerpt

TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share but missed on revenue for the second quarter of ...

Article found on: investorplace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo